Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway

H Nakanishi, C Taccioli, J Palatini, C Fernandez-Cymering, R Cui, T Kim, S Volinia, C M Croce
Oncogene Feb 18, 2013
… Corporation (International Plaza, Singapore) and maintained in Epilife basal medium with 1% epilife-defined growth supplement and 1% antibiotics and used between passages 4 and 8. Human normal tissue, tongue and pharynx were obtained from BioChain (Newark, CA …

Leave a Reply